Hepatitis B and hepatitis C Virus in Thai blood donors

Southeast Asian Journal of Tropical Medicine and Public Health

Volumn 42, Issue 3, 2011, Pages 609-615

  Chimparlee, Nitinan ^a   Oota, Sineenart ^b   Phikulsod, Soisaang ^b   Tangkijvanich, Pisit ^a   Poovorawan, Yong ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

^b THAI RED CROSS AIDS RESEARCH CENTRE   (Thailand)

Author keywords

Blood donor; Hepatitis B; Hepatitis C; Thailand

Indexed keywords

EID: 79961043475     PISSN: 01251562     EISSN: 26975718     Source Type: Journal    
DOI: None     Document Type: Review

References (34)

1. Allain JP. Occult hepatitis B virus infection. Transfus Clin Biol 2004; 11: 18-25.
2. Bureau of General Communicable Disease. Thailand's expanded programme on immunization. Nonthaburi: Ministry of Public Health, 2004: 1-108 (in Thai).
3. Bureau of General Communicable Disease. Thailand's expanded programme on immunization. Nonthaburi: Ministry of Public Health, 2005: 1-50 (in Thai).
4. Bureau of General Communicable Disease. Thailand's expanded programme on immunization. Nonthaburi: Ministry of Public Health, 2007: 1-241 (in Thai).
5. Bureau of General Communicable Disease. National vaccine coverage survey of Thailand. Nonthaburi: Ministry of Public Health, 2008: 24-32 (in Thai).
6. Burra P. Hepatitis C. Semin Liver Dis 2009; 29: 53-65.
7. Carreño V, Bartolomé J, Castillo I, Quiroga JA. Hepatitis C virus replication in patients with occult hepatitis C virus infection. Hepatology 2009; 49: 2128-9.
8. Centers for Disease Control and Prevention (CDC). Inactivated hepatitis B virus vaccine. Recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR Morb Mortal Wkly Rep 1982; 31: 317-28.
9. Chongsrisawat V, Yoocharoen P, Theamboonlers A, et al. Hepatitis B seroprevalence in Thailand: 12 years after hepatitis B vaccine integration into the national expanded programme on immunization. Trop Med Int Health 2006; 11 :1496-502. (Pubitemid 44450554)
10. Chunsuttiwat S, Biggs BA, Maynard J, et al. Integration of hepatitis B vaccination into the expanded programme on immunization in Chonburi and Chiangmai provinces, ThailandVaccine 1997; 15: 769-74. (Pubitemid 27240493)
11. De Marco L, Gillio-Tos A, Fiano V, et al. Occult HCV infection: an unexpected finding in a population unselected for hepatic disease. PLoS One 2009; 4: e8128.
12. Dodd R, Kurt Roth W, Ashford P, Dax EM, Vyas G. Transfusion medicine and safetyBiologicals 2009; 37: 62-70.
13. Jutavijittum P, Jiviriyawat Y, Yousukh A, Hayashi S, Toriyama K. Evaluation of a hepatitis B vaccination program in Chiang Mai, ThailandSoutheast Asian J Trop Med Public Health 2005; 36: 207-12. (Pubitemid 40577022)
14. Kunanuson C. Blood doner recruitment criteria. J Soc Hematol Thai Nat Blood Cent 1991; 1:4 47-52 (in Thai).
15. Liang TJ- Hepatitis B the virus and disease 2009. Hepatology. 2009; 49(suppl 5): S13-21.
16. Liang X, Bi S, Yang W, et al. Epidemiology serosurvey of hepatitis B in China - Declinig HBV prevalence due to hepatitis B vaccinationVaccine 2009a; 27: 6550-7.
17. Liang X, Bi S, Yang W, et al. Evaluation of the impact of hepatitis B vaccination among children born during 1992 - 2005 in ChinaJ Infect Dis 2009b; 200: 39-47.
18. Liaw YF. Antiviral therapy of chronic hepatitis B opportunities and challenge in AsiaJ Hepatol 2009; 51: 403-10.
19. Liu CJ, Chen DS, Chen PJ. Epidemiology of HBV infection in Asian blood donors: emphasis on occult HBV infection and the role of NAT. J Clin Virol 2006; 36 (suppl 1): S33-44.
20. Marcellin P. Hepatitis B and hepatitis C in 2009. Liver Int 2009; 29 (suppl 1): 1-8.
21. Myrmel H, Ulvestad E, Asjo B. The hepatitis C virus engima. APMIS 2009; 117: 427-39.
22. National Blood Center (NBC). National blood policy. Nonthaburi: Udomsuksa Publishing, 1989; 1-28 (in Thai).
23. National Blood Center (NBC). Donor selection guidline. Bangkok: Udomsuksa Publishing, 2009; 1-49 (in Thai).
24. Ni YH, Chen DS. Hepatitis B vaccination in children: The Taiwan experience. Pathol Biol 2010; 58: 296-300.
25. Ozaslan E, Purnak T. Controversies about occult hepatitis B virus infectionWorld J Gastroenterol 2009; 15: 4986-7.
26. Park NH, Chung YH, Lee HS. Impacts of vaccination on hepatitis B vijal infections in Korea over a 25-year periodIntervirology 2010; 53: 20-8.
27. Pham TN, Coffin CS, Michalak TI. Occult hepatitis C virus infection: what does it mean? Liver Int 2010; 30: 502-11.
28. Phikulsod S, Oota S, Tirawatnapong T, et al. One-year experience of nucleic acid technology testing for human immunodeficiency virus type 1, hepatitis C virus, and hepatitis B virus in Thai blood donationsTransfusion 2009; 49: 1126-35.
29. Poovorawan Y, Chongsrisawat V, Theamboonlers A, Bock HL, Leyssen M, Jacquet JM. Persistence of antibodies and immune memory to hepatitis B vaccine 20 years after infant vaccination in ThailandVaccine 2010; 28: 730-6.
30. Poovorawan Y, Chongsrisawat V, Theamboonlers A, et al. Evidence of protection against clinical and chronic hepatitis B infection 20 years after infant vaccination in a high endemicity regionJ Viral Hepat 2011; 18: 369-75.
31. Poovorawan Y, Theamboonlers A, Vimolket T, et al. Impact of hepatitis B immunisation as part of the EPIVaccine 2000; 19: 943-9.
32. Tharmaphornpilas P, Rasdjarmrearnsook AO, Plianpanich S, Sa-nguanmoo P, Poovorawan Y. Increased risk of developing chronic HBV infection in infants born to chronically HBV infected mothers as a result of delayed second dose of hepatitis B vaccinationVaccine 2009; 27: 6110-5.
33. Thomson BJ. Hepatitis C virus: the growing challenge. Br Med Bull 2009; 89: 153-67.
34. Zanetti AR, Dammeb PV, Shouval D. The global impact of vaccination against hepatitis B: a historical reviewVaccine 2008; 26: 6266-73.